Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Young

Showing results (161-170 of 208) with videos related to

Pageof 21
Sort By:
Human Reproduction (Oxford, England)|March 15, 2012
SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system developmentJacques Young, Corinne Metay, Jerome Bouligand, et al.
Pituitary|November 7, 2015
Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's diseaseMaria Fleseriu, Rosario Pivonello, Jacques Young, et al.
The Journal of Clinical Endocrinology and Metabolism|May 11, 2019
Illicit Upregulation of Serotonin Signaling Pathway in Adrenals of Patients With High Plasma or Intra-Adrenal ACTH LevelsJulie Le Mestre, Céline Duparc, Yves Reznik, et al.
Case Reports in Endocrinology|July 26, 2019
Diabetes Mellitus, Extreme Insulin Resistance, and Hypothalamic-Pituitary Langerhans Cells HistiocytosisMathilde Sollier, Marine Halbron, Jean Donadieu, et al.
European Journal of Endocrinology|August 7, 2023
Increase in intracellular and extracellular myocardial mass in patients with acromegaly: a cardiac magnetic resonance imaging studyPeter Wolf, Khaoula Bouazizi, Nadjia Kachenoura, et al.
Plos One|August 13, 2013
R31C GNRH1 mutation and congenital hypogonadotropic hypogonadismLuigi Maione, Frederique Albarel, Philippe Bouchard, et al.
Neuroendocrinology|February 20, 2020
Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann SyndromeSara Barraud, Brigitte Delemer, Céline Poirsier-Violle, et al.
European Journal of Endocrinology|June 10, 2024
Gonadotropic status in adult women with pituitary stalk interruption syndromeAglaé Terray, Bertrand Baussart, Marie Zins, et al.
The Lancet. Diabetes & Endocrinology|March 4, 2024
Classes and predictors of reversal in male patients with congenital hypogonadotropic hypogonadism: a cross-sectional study of six international referral centresAndrew A Dwyer, Isabella R McDonald, Biagio Cangiano, et al.
European Journal of Endocrinology|November 21, 2014
Ovarian macrocysts and gonadotrope-ovarian axis disruption in premenopausal women receiving mitotane for adrenocortical carcinoma or Cushing's diseaseSylvie Salenave, Valérie Bernard, Christine Do Cao, et al.
Pageof 21

Showing results (161-170 of 208) with videos related to

Sort By:
Pageof 21
Human Reproduction (Oxford, England)|March 15, 2012
SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system developmentJacques Young, Corinne Metay, Jerome Bouligand, et al.
Pituitary|November 7, 2015
Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's diseaseMaria Fleseriu, Rosario Pivonello, Jacques Young, et al.
The Journal of Clinical Endocrinology and Metabolism|May 11, 2019
Illicit Upregulation of Serotonin Signaling Pathway in Adrenals of Patients With High Plasma or Intra-Adrenal ACTH LevelsJulie Le Mestre, Céline Duparc, Yves Reznik, et al.
Case Reports in Endocrinology|July 26, 2019
Diabetes Mellitus, Extreme Insulin Resistance, and Hypothalamic-Pituitary Langerhans Cells HistiocytosisMathilde Sollier, Marine Halbron, Jean Donadieu, et al.
European Journal of Endocrinology|August 7, 2023
Increase in intracellular and extracellular myocardial mass in patients with acromegaly: a cardiac magnetic resonance imaging studyPeter Wolf, Khaoula Bouazizi, Nadjia Kachenoura, et al.
Plos One|August 13, 2013
R31C GNRH1 mutation and congenital hypogonadotropic hypogonadismLuigi Maione, Frederique Albarel, Philippe Bouchard, et al.
Neuroendocrinology|February 20, 2020
Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann SyndromeSara Barraud, Brigitte Delemer, Céline Poirsier-Violle, et al.
European Journal of Endocrinology|June 10, 2024
Gonadotropic status in adult women with pituitary stalk interruption syndromeAglaé Terray, Bertrand Baussart, Marie Zins, et al.
The Lancet. Diabetes & Endocrinology|March 4, 2024
Classes and predictors of reversal in male patients with congenital hypogonadotropic hypogonadism: a cross-sectional study of six international referral centresAndrew A Dwyer, Isabella R McDonald, Biagio Cangiano, et al.
European Journal of Endocrinology|November 21, 2014
Ovarian macrocysts and gonadotrope-ovarian axis disruption in premenopausal women receiving mitotane for adrenocortical carcinoma or Cushing's diseaseSylvie Salenave, Valérie Bernard, Christine Do Cao, et al.
Pageof 21